Dr. Yong Du's lab at Johns Hopkins University focuses on developing advanced imaging systems for radiopharmaceutical therapy, a cutting-edge treatment for cancer. They are working to create tools that allow researchers to observe and understand how these therapies target cancer cells at a microscale level, significantly improving the efficacy and safety of treatments. The lab's projects aim to better visualise the distribution and effect of targeted radiation therapies in small animal models and potentially enhance clinical application in humans.

Dr. Duan Xu's lab focuses on improving MRI techniques to evaluate glioma patients, who have the most common type of brain tumor. The lab aims to develop new tools and software that make it easier to interpret MR images and track the progression of tumors over time. By integrating metabolic imaging and enhancing the imaging workflow, the lab works to provide clearer insights into tumor behavior and treatment response, ultimately aiming to improve patient outcomes.

Dr. James S. Duncan's lab at Yale University focuses on improving treatments for autism spectrum disorder (ASD) and liver cancer using advanced imaging techniques and machine learning. For autism, the team aims to develop deep learning models that can identify brain biomarkers and predict treatment outcomes. In liver cancer, they explore innovative imaging methods to characterize tumor environments and improve patient care through personalized treatment strategies based on non-invasive biomarkers.

Dr. Jessilyn P Dunn's lab at Duke University focuses on innovative ways to detect prediabetes and type 2 diabetes early in adults using mobile technologies. The research aims to utilize data from everyday smart devices like smartphones and smartwatches to improve current screening methods. This lab develops wearable technologies that help monitor glucose levels and assess diabetes risk, benefiting the many people who are unaware of their diabetic conditions.

Dr. Richard Edden's lab focuses on using advanced Magnetic Resonance Spectroscopy (MRS) techniques to study brain chemistry throughout different stages of human development, particularly in childhood. The lab develops innovative methods to measure essential neurochemicals non-invasively, which can help investigate brain development and disorders. Their work is closely connected with the Healthy Brain and Child Development Study, aiming to enhance our understanding of neurodevelopmental trajectories and challenges.

David Eddington's lab focuses on understanding how the bacterium Streptococcus pneumoniae, a major cause of pneumonia and meningitis, acquires antibiotic resistance through genetic transformation. The lab utilizes microfluidics technology to study bacteria in small environments, enabling detailed examination of how genetic material is exchanged between bacterial cells. By investigating these mechanisms, the lab aims to develop better strategies for combating bacterial infections that have become increasingly resistant to current treatment methods.

Dr. Adam Thomas Eggebrecht's lab focuses on improving the diagnosis and treatment of autism spectrum disorder (ASD) using advanced technology. The lab is working on a new method that combines wearable brain imaging with a computerized assessment to study motor imitation in children. This work aims to understand how motor imitation can help distinguish ASD from other developmental disorders, ultimately enhancing diagnostic accuracy and supporting better clinical care.

Dr. Ahmed El Kaffas's lab at UC San Diego focuses on developing innovative imaging technologies to better understand liver cancers. They use advanced 3D ultrasound techniques to create detailed maps of tumor blood vessels, which can help predict how well a patient is responding to treatments. Their research has the potential to improve diagnostics and support more personalized treatment plans for liver malignancies.

Dr. Anna Tarakanova's research focuses on understanding the structure and mechanics of elastin, a protein that allows arteries to stretch and recoil, providing efficient blood circulation. By investigating how aging and disease impact elastin's properties, her lab aims to develop new strategies for preventing and treating cardiovascular issues. The research combines advanced modeling techniques and experimental approaches to uncover the connections between molecular structure and function in arterial tissues.

Dr. Jutta M Ellermann's research lab at the University of Minnesota focuses on improving knee imaging techniques using advanced 7 Tesla (7T) MRI technology. The aim is to develop and optimize methods that will enhance the diagnosis and management of osteoarthritis, especially related to meniscal root tears. The lab combines engineering with biomedical research to explore the full capabilities of 7T MRI, which could significantly impact patient treatment and outcomes.

Dr. Benjamin M. Ellingson's lab at UCLA focuses on understanding glioblastoma, an aggressive form of brain cancer, and developing better imaging methods to guide treatment. His team investigates how certain proteins and imaging techniques can predict patient response to therapies that block blood vessel growth. By combining advanced MRI imaging with clinical data, they aim to create reliable biomarkers that help tailor treatments, improving outcomes for patients battling this challenging disease.

Mingzhou Ding's lab at the University of Florida focuses on developing advanced AI technologies to generate and understand emotional images. Their research aims to combine artificial intelligence with neuroscience to improve how we study and treat psychiatric disorders related to emotions. This multidisciplinary work has the potential to significantly impact both the scientific community and clinical practices by providing high-quality emotional stimuli and insights into brain responses.

Dr. Holly Prigerson's lab focuses on improving the quality of end-of-life care for cancer patients and their families. Her research addresses the emotional and psychosocial challenges faced by patients in the last stages of their lives, aiming to educate oncologists on better communication about prognosis and treatment options. The lab also emphasizes the role of caregivers and healthcare chaplains in providing comprehensive support, while developing interventions to alleviate patient distress and promote advance care planning.

Dr. Benjamin Keselowsky's lab focuses on developing advanced enzyme therapies to treat psoriasis, a chronic inflammatory skin condition. The lab studies both tissue-anchored and circulating forms of these enzymes to understand how they can effectively reduce inflammation and restore metabolic balance in immune cells. By innovatively engineering these therapeutic proteins, the lab seeks to bring new solutions to patients suffering from autoimmune diseases.

Dr. Carrie R. McDonald leads a research lab at UC San Diego focused on understanding the connection between epilepsy and brain aging in older adults. Her lab investigates how cognitive decline and Alzheimer's disease are linked to epilepsy, aiming to identify risk factors that can be modified to improve patient outcomes. Through advanced imaging and genetic studies, the research seeks to predict treatment responses in epilepsy and enhance patient care for older adults.

Dr. Frederick H. Epstein's lab at the University of Virginia focuses on improving heart health through advanced imaging techniques. The lab studies epicardial adipose tissue, which is the fat surrounding the heart, and its impact on conditions like heart failure and coronary microvascular disease. By developing innovative methods to visualize this tissue, researchers aim to uncover new insights into cardiovascular diseases and potential therapeutic approaches.

Dr. Gari David Clifford's lab focuses on utilizing advanced digital technologies and artificial intelligence to improve healthcare outcomes. They are developing tools to enhance the detection of Alzheimer's disease through eye-tracking to evaluate memory, and creating low-cost ultrasound technology to monitor maternal and fetal health in underserved communities. These innovative approaches aim to make critical health assessments more accessible and equitable across diverse populations.

Dr. Ahmet Erdemir's lab focuses on improving the accuracy and consistency of knee biomechanics simulations. They work on developing standardized modeling workflows to ensure that simulations can reliably predict knee mechanics, which is important for understanding musculoskeletal diseases and improving surgical outcomes. The research aims to make computational models more accessible and reproducible, which can ultimately help in clinical decision-making and personalized medicine for patients with knee issues.

Dr. Agata Exner's research focuses on enhancing cancer diagnosis and treatment using innovative ultrasound technologies. By developing specialized nanoparticles called nanobubbles, her lab aims to improve prostate cancer biopsy accuracy and predict how well tumors will respond to nanoparticle-based chemotherapy. This work seeks to revolutionize personalized cancer therapy by providing real-time imaging methods to guide treatment decisions.

Dr. Andrea Facciabene leads innovative research at the University of Pennsylvania focusing on cancer treatment, specifically exploring the combination of radiation therapy with T-cell therapy and modifications of the gut microbiome. Their work seeks to enhance antitumor responses in patients with lymphomas and lung cancer, aiming to redefine treatment strategies to prolong patients' survival. By studying how gut bacteria can impact cancer therapies, the lab is at the forefront of novel cancer treatment research that could lead to groundbreaking advancements in oncology.